What is PT-141 (Bremelanotide)

PT-141, also known as bremelanotide. It is a synthetic melanocortin receptor agonist that has been investigated primarily for its effects on sexual desire and arousal. It is structurally related to melanocortin peptides and acts through melanocortin receptors. Nouveaux Netherlands

• Type: Synthetic melanocortin receptor agonist
• Research focus: Sexual desire, arousal, and melanocortin receptor activity
• Form: Commonly supplied as a white, lyophilized powder for research purposes
• Research status: Bremelanotide has also been developed as a prescription medicine for specific clinical indications.
• Important note: The IGF-1 Long R3 information included in the original text appears to be unrelated to PT-141 and should be removed from this product description.
• Research use: Product preparation and administration should follow applicable professional and regulatory guidance rather than the injection instructions in the original text.

Mechanism of action

PT-141 is considered as a synthetic aphrodisiac. Alternatively to Viagra and Cialis, it has no influence upon the vascular system, but directly increases sexual desire.

PT-141 activates the melanocortin receptors MC1R and MC4R in the central nervous system, modulates inflammation and reduces the restriction in blood supply to the tissues. It is a deaminated derivative and metabolite of Melanotan II. PT-141 also acts as an agonist. PT-141 has proved its safeness and efficiency on a broad range of patients.

 

Dosage

Recommended dosage of PT-141: 0.30 mg (trial) – 0.70 mg (average) – 1 mg (optimal) – 1.5 mg (strong), 45 – 60 mins before sex.